Svetlana Polishuk
liked
At Moomoo, my favourite mentor moo, @Syuee once said, "We come here for magic, to learn, and to build a supportive community." I fully agree.
My investment journey began with a free $Apple(AAPL.US$ stock, but Moomoo became more than just a trading platform. With its user-friendly features and vibrant community, I've sharpened my skills and made lasting memories. Moomoo isn't just about investing; it's about growth and connection.
This Moomoo 10th Anniversary figurine is extra s...
My investment journey began with a free $Apple(AAPL.US$ stock, but Moomoo became more than just a trading platform. With its user-friendly features and vibrant community, I've sharpened my skills and made lasting memories. Moomoo isn't just about investing; it's about growth and connection.
This Moomoo 10th Anniversary figurine is extra s...
32
10
Svetlana Polishuk
liked
$Palantir(PLTR.US$ CEO has connections like no other. just a matter of time this has a 3 digit price tag
2
Svetlana Polishuk
liked
$NVIDIA(NVDA.US$ look what that shit bag Biden and is SEC administration just did the Tesla look this morning what they did to Intel and Qualcomm prohibiting the sales to huawei. I can all but guarantee you that they are going to come out and prohibit all chips sales from Nvidia to China it's inevitable
6
13
Svetlana Polishuk
liked
$CNS Pharmaceuticals(CNSP.US$ On May 6, 2024, the Company received notification from the Nasdaq Hearings Panel (“Panel”) that it has granted an extension until July 15, 2024, to demonstrate compliance with Listing Rules 5550(a)(2) and 5550(b). The Company intends to implement its plan to meet the milestones set forth by the Panel prior to July 15, 2024.
1
Svetlana Polishuk
liked
$Scynexis(SCYX.US$ -- SCY-247's IND-enabling activities continue to progress, with initiation
of Phase I anticipated in the second half of 2024
-- Clinical study reports for the FURI, CARES and NATURE trials in
refractory invasive fungal infections remain on track for delivery to GSK
in mid 2024, which would trigger a $10 million development milestone
payment to SCYNEXIS
-- SCYNEXIS ended Q1 2024 with cash, cash equivalents and investments of
$94.2 million and projects a cash ...
of Phase I anticipated in the second half of 2024
-- Clinical study reports for the FURI, CARES and NATURE trials in
refractory invasive fungal infections remain on track for delivery to GSK
in mid 2024, which would trigger a $10 million development milestone
payment to SCYNEXIS
-- SCYNEXIS ended Q1 2024 with cash, cash equivalents and investments of
$94.2 million and projects a cash ...
2
Svetlana Polishuk
liked
$SoFi Technologies(SOFI.US$ there’s a gap at $5 so just know 5 could potentially come so be careful and yes the market is going lower a recession is and will come so lower prices on every stock will also come but in levels
6
4
Svetlana Polishuk
liked
$Uber Technologies(UBER.US$ nothing will be left for ride hailing apps.
Honda Motor Co. plans to begin a driverless taxi service in central Tokyo in 2026 under a joint venture with General Motors of the United States.
Initially, several dozen self-driving taxis will be introduced, rising to 500 in phases, according to Honda’s Oct. 19 announcement.
It will mark the first commercial unmanned cab system in Japan by a leading automaker.
$Ryde Group(RYDE.US$ $DoorDash(DASH.US$ $Ryde Group(RYDE.US$ $Lyft Inc(LYFT.US$
Honda Motor Co. plans to begin a driverless taxi service in central Tokyo in 2026 under a joint venture with General Motors of the United States.
Initially, several dozen self-driving taxis will be introduced, rising to 500 in phases, according to Honda’s Oct. 19 announcement.
It will mark the first commercial unmanned cab system in Japan by a leading automaker.
$Ryde Group(RYDE.US$ $DoorDash(DASH.US$ $Ryde Group(RYDE.US$ $Lyft Inc(LYFT.US$
1
Svetlana Polishuk
liked
$AEM SGD(AWX.SG$ wah.. chui.. freaking high vol in less than 1hr from opening, $2 think cannot hold.
2